This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Case Report

A Case of Agranulocytosis Secondary to Rechallenge With Clozapine Following Severe Neutropenia During Previous Therapy

Unax Lertxundi, PhD; Pedro Sanchez, MD; Rafael Hernandez, MD; and Edorta Elizagarate, MD

Published: December 15, 2011

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Data providing information on outcome in patients rechallenged with clozapine after previous agranulocytosis during clozapine treatment are scarce. Clinicians have been urged to publish their cases, since a greater number of cases in the literature may enable the detection of plausible risk factors.

We report the case of a 46-year-old man diagnosed with paranoid schizophrenia and uncontrollable violent behavior who was rechallenged with clozapine after a severe neutropenia during previous therapy.

Volume: 72

Quick Links: Schizophrenia and Schizoaffective Disorders

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...